Register Now - Unlocking Longitudinal Patient-Reported Outcomes: The Untapped Value of Specialty Pharmacyocking
|Articles|June 4, 2015

Merge eClinical Announces New Mobile App

Study Connect™ App Enables the Mobile Management of Randomization, Inventory Management and Unblinding in Clinical Trials

Study Connect™, a new mobile app from Merge eClinical, allow users of its eClinicalOS (eCOS) to perform a wide array of clinical trial management functions from their iOS-based mobile devices.

Seamlessly integrated with eCOS, Study Connect™enables researchers to: 

·       Manage randomization of subjects

·       Coordinate dispensing and inventory management

·       Unblind individual subjects, as circumstances warrant

·       Stay connected with real-time customized notifications

·       Monitor enrollment and establish milestone alerts

·       Share top-level statistics for each study with key stakeholders using the study dashboard

·       Expedite approval response times for critical study decisions such as patient study eligibility

·       Maintain security with the ability to set customized role-based permissions for individual studies.

 

Read the full release here. 


Related to this article

Where AI Leads in Trial Design—and Where Humans Still Need To
In this video interview, Claire Riches, VP of clinical solutions at Citeline, makes the case for AI as a sophisticated strategic advisor in trial design while arguing that humans must remain in the lead—especially when factors the model can't fully account for are at stake.